Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer
GeriPal
MARCH 2, 2023
2006 Transcript Eric: Welcome to the GeriPal Podcast. By 2015 that number increased to 4% of US adults. There are a lot of reasons that may explain the massive increase in use of these drugs. One thing is clear, it is not because people are using it for FDA approved indications. Cochrane Database of Systematic Reviews Review. Annals of IM.
96 
Let's personalize your content